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Abstract
Purpose—To determine the impact of preoperative nutritional status on the development of 
surgical complications following cystectomy using the American College of Surgeons National 
Surgical Quality Improvement Program (ACS-NSQIP).
Methods—We performed a retrospective review of the NSQIP 2005–2012 Participant Use Data 
Files. ACS-NSQIP collects data on 135 variables, including pre- and intraoperative data and 30-
day post-operative complications and mortality on all major surgical procedures at participating 
institutions. Preoperative albumin (<3.5 or >3.5 g/dl), weight loss 6 months before surgery 
(>10%), and BMI were identified as nutritional variables within the database. The overall 
complication rate was calculated and predictors of complications were identified using 
multivariable logistic regression models.
Results—1,213 patients underwent cystectomy for bladder cancer between 2005–2012. The 
overall 30-day complication rate was 55.1% (n=668). While 14.7% (n=102) had a preoperative 
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albumin <3.5 g/dL, 3.4% had >10% weight loss in the 6 months prior to surgery, and the mean 
BMI was 28 kg/m2. After controlling for age, sex, medical comorbidities, medical resident 
involvement, operation year, operative time and prior operation, only albumin <3.5g/dl was a 
significant predictor of experiencing a postoperative complication (p=0.03). This remained 
significant when albumin was evaluated as a continuous variable (p=0.02)
Conclusions—Poor nutritional status measured by serum albumin is predictive of an increased 
rate of surgical complications following radical cystectomy. This finding supports the importance 
of preoperative nutritional status in this population and highlights the need for the development of 
effective nutritional interventions in the preoperative setting.
Keywords
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Introduction
Radical cystectomy (RC) with pelvic lymph node dissection is the standard of care for 
muscle invasive bladder cancer (MIBC). Despite improvements in surgical technique and 
improved post-operative recovery pathways, RC remains highly morbid, with a 28–64% 90-
day complication rate1,2, 27% 90-day re-admission rate3, and 3–7% 90-day mortality 
rate.2–4
Pre-operative malnutrition is one potentially significant contributor to the high morbidity 
and mortality of RC. The association between malnutrition and poor surgical outcomes is 
well established in the general surgery literature.5–7 However, only a small number of 
studies examine nutritional predictors of surgical outcomes after urologic procedures.4,8–12 
While nutritional deficiency lacks a universal definition, researchers and clinicians often 
define malnutrition using a combination of unintentional weight loss, suboptimal body mass 
index (BMI), and poor appetite/anorexia.13 Additionally, serum markers such as albumin 
and prealbumin, in combination with C-reactive protein, are often used to evaluate 
nutritional status; however, they appear to be more correlative as surrogate markers for 
disease severity and predictors of operative morbidity and mortality.14
The objective of this study was to investigate which indicators of pre-operative malnutrition 
were associated with increased perioperative complications after RC for bladder cancer 
using a large, national database. We hypothesized that serum albumin < 3.5 gm/dL, 
excessive pre-operative weight loss, and suboptimal body mass index (BMI) were 
independent predictors of complications within 30 days after RC.
Materials and Methods
We performed a retrospective review of the American College of Surgeons National Quality 
Improvement Program (NSQIP) database from 2005–2012. This nationally validated, risk-
adjusted, prospectively maintained database includes 135 variables including 30-day 
morbidity and mortality outcomes for major surgical procedures at over 450 participating 
institutions across the United States and is specifically designed to evaluate post-surgical 
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outcomes.15 Cases of RC performed for bladder cancer were extracted from the database 
using ICD-9 codes for bladder neoplasm (188 and 188.x) including carcinoma in situ (233.7) 
and Current Procedural Terminology codes for radical cystectomy (51570, 51575, 51580, 
51585, 51590, 51595, 51596, and 51597). Patients who underwent RC for diagnoses other 
than bladder cancer were excluded. Nutritional factors including pre-operative albumin, 
weight loss >10% within 6 months prior to surgery, and BMI were extracted using the 
corresponding preoperative codes.
Statistical analyses
Univariable analyses were performed to describe the patient population in terms of 
demographic, prognostic, and treatment factors. These factors included age, sex, race, 
medical comorbidities, smoking and alcohol history, history of pre-operative surgery or 
blood transfusion, year of operation, presence and training level of resident in operating 
room, prior radiation therapy, pre-operative acute renal failure (defined as a rising Cr > 3 
mg/dL within 24 hours prior to surgery), chronic steroid use, and American Society of 
Anesthesia (ASA) classification. Missing data were excluded. Bivariable analyses were 
performed to evaluate 30-day complication rates based on pre-operative nutrition factors. 
Chi-square analyses were used to compare complications between groups of patients with 
pre-operative serum albumin above and below a threshold of 3.5 g/dL, and between patients 
who did and did not experience >10% weight loss in the 6 months prior to surgery. A serum 
albumin cut point of 3.5 g/dL was examined based on prior studies demonstrating the 
predictive utility of this threshold.4,10,11 The Mann-Whitney U-test was used to evaluate 
complication rates based on BMI as a non-normal continuous variable. Albumin was also 
reexamined as a continuous variable as a sensitivity analysis.
Multivariable logistic regression analyses were performed to determine which pre-operative 
nutritional parameters were independent predictors of at least one post-operative 
complication within 30 days. Initial models included the influential predictors from 
bivariable analysis (defined as those with a p-value less than 0.2). The final models were 
selected using backwards elimination of non-significant variables (at the 5% level of 
significance) so that final models included only the necessary variables affecting the 
relationship between nutritional parameters and complication rate. SAS 9.3 (SAS Institute, 
Cary NC, USA) software was used for all statistical analyses. The University of North 
Carolina Institutional Review Board exempted this study from review.
Results
A total of 1,431 patients underwent RC at participating NSQIP centers from 2005–2012. Of 
these, 218 (15.2%) were excluded based on diagnoses other than bladder cancer. Overall, 
1,213 patients underwent RC for bladder cancer from 2005–2012. Of these patients, 691 
(57.0%) had recorded pre-operative serum albumin levels, 1,201 (99.0%) had BMI data, and 
all patients had data with regard to pre-operative weight loss.
Patients characteristics were different between those with albumin <3.5 g/dL and those with 
normal albumin in several categories. (Table Ia) Patients with low serum albumin were more 
likely to be female (36 vs 21%, p<0.01), African American (14 vs 4%, p<0.01), and partially 
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dependent for activities of daily living (9 vs 1%, p<0.01). Patients with low serum albumin 
were also more likely to have pre-operative acute renal failure (6 vs 0.7%, p<0.01), received 
radiotherapy for malignancy in the 90 days prior to surgery (3 vs 0.2%, p<0.01), received 
pre-operative blood transfusion (8 vs 1%, p<0.01), a higher ASA classification (3–5 vs 1–2, 
p=0.01) and a lower BMI (mean 26.0 vs 27.9 kg/m2, p<0.01). Patients with low albumin 
were less likely to have had a resident in the operating room during surgery (p=0.02). Lower 
BMI (mean 24.0 vs 28.0 kg/m2, p<0.01) and increased pre-operative transfusion requirement 
(13 vs 2%, p<0.01) were the only significant differences between patients who lost greater 
than 10% of body weight prior to surgery and those who did not. (Table Ib) BMI was 
significantly associated with several patient characteristics. Patients with lower BMI were 
more likely to be older (p<0.01), female (p=0.01), have a smoking (p<0.01) and alcohol 
history (p=0.02), a lower ASA classification (1–2 vs 3–5, p=0.01), and have had excessive 
pre-operative weight loss (p<0.01). Patients with increased BMI were more likely to have 
hypertension (p<0.01), diabetes (p<0.01) and a resident present in the OR (p=0.01). 
Increased age was associated with lower BMI while longer operative time was associated 
with increased BMI. (Table Ic).
At least one complication occurred in 668 out of 1,213 patients (55.1%) patients within 30 
days of RC for bladder cancer. On bivariable analysis, patients with albumin <3.5 g/dL had a 
significantly higher overall complication rate than those with pre-operative albumin >3.5 
g/dL (67 vs 55%, p=0.03). Conversely, neither excessive pre-operative weight loss (65 vs 
55% p=0.20) nor BMI (p=0.43) were associated with significantly increased complications. 
(Appendix Table I)
Examining specific types of complications, those patients with pre-operative albumin <3.5 
g/dL were significantly more likely to have a respiratory complication (19 vs 6%, p<0.01) 
than patients with normal albumin. These patients were also more likely to have a 
cardiovascular complication; however, this difference did not reach statistical significance (5 
vs 2%, p=0.56) (Appendix Table IIa). No specific complications were significantly 
associated with excessive weight loss prior to surgery. (Appendix Table IIb) Increased BMI 
was significantly associated with superficial wound infection (p<0.01), wound dehiscence 
(p=0.01), renal insufficiency (p=0.01), and reoperation (p=0.05). Bleeding requiring 
transfusion was more common in patients with lower BMI (p=0.02). (Appendix Table IIc)
On multivariable logistic regression, only pre-operative serum albumin was a significant 
predictor of complications when adjusting for all other confounding variables (p=0.03) 
(Table IIa) These potentially influential variables (on bivariable analysis with p<0.2) 
included age (p=0.01), sex (p=0.02), resident presence in OR (p<0.01), year of operation 
(p<0.01), pre-operative smoking history (p=0.19), pre-operative pulmonary (p=0.10) or 
cardiac comorbidity (p=0.04), pre-operative acute renal failure (p=0.16), prior operation 
within 30 days (p=0.03), operative time (<0.01), ASA classification (p<0.01), and pre-
operative blood transfusion (p=0.04). After adjusting for these variables, patients with 
albumin < 3.5 g/dL had almost twice the odds of having at least one complication compared 
to patients with serum albumin ≥3.5 g/dL prior to surgery (OR 1.79; 95% CI 1.06, 3.03. 
p=0.03) (Table IIa). As a continuous variable, pre-operative serum albumin remained a 
significant predictor, with a 0.5 g/dL decrease resulting in 1.2 times the odds of least one 
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complication (OR 1.20; 95% CI 1.02, 1.40. p=0.02 per 0.5 g/dL decrease). (Table IIb) 
Neither pre-operative weight loss of >10% of body weight (OR 1.05; 95% CI 0.44, 2.52, 
p=0.92) nor BMI (OR 1.01; 95% CI 0.98, 1.04, p=0.73) was significantly associated with 
increased post-operative complications after adjusting for confounding variables. (Table IIa)
Discussion
Our analysis of the NSQIP database demonstrates that patients with pre-operative albumin < 
3.5 g/dL have nearly twice the risk of a complication within 30 days of RC for bladder 
cancer compared to patients with a normal albumin level. The predictive value of albumin 
remains significant on our sensitivity analysis as a continuous variable. Conversely, 
complications were not associated with BMI or weight loss >10% in 6 months prior to 
surgery. Lack of association for BMI and weight loss may be secondary to a homogeneous 
BMI range and small sample size, respectively.
With regard to albumin, our findings support two single institution retrospective reports that 
low pre-operative serum albumin predicts increased post-operative complications after 
RC.11,12 Lambert et al reported that patients with a serum albumin < 3.5 g/dL had a 22% 
greater overall complication rate compared to patients with a normal albumin (>3.5 g/dL), 
even when controlling for multiple covariates.11 However, their sample size was small (n = 
187), and the study was not specifically designed to evaluate complications, which were 
therefore neither systematically nor prospectively ascertained. Garg et al also demonstrated 
that hypoalbuminemia significantly increased the risk of complications within 90 days of 
RC.12 Specifically, neurologic and wound complications occurred more frequently in 
patients with decreased pre-operative serum albumin, while other major complications, 
including cardiac, gastrointestinal, genitourinary, infectious, bleeding, pulmonary, and 
thromboembolic were not significantly associated. Despite a larger cohort (N=1097), this 
series included only patients from a single tertiary specialty oncology hospital.12
In contrast to these single institution studies, our study population is drawn from over 450 
academic and community hospitals across the United States, expanding the external validity 
of the findings. Furthermore, neither study examined additional nutritional predictors of 
complications not addressed in previous reports.
Prior studies have also suggested the importance of serum albumin on mortality after RC. 
Gregg et al10, Lambert et al11, and Garg et al12 reported that pre-operative hypoalbuminemia 
significantly increased 90-day mortality after RC in their respective single institution, 
retrospective studies. Hollenbeck et al4 used a prior iteration of the Veterans Administration 
NSQIP dataset to demonstrate that patients undergoing RC with a pre-operative serum 
albumin < 3.5 gm/dL had 12 times the odds of 90 day mortality compared to those patients 
with a normal serum albumin.4
Malnutrition increases the risk of adverse surgical outcomes by impairing immune 
function16, contributing to sarcopenia and impaired muscle function16, delaying 
mobilization and impairing cardiopulmonary function.17,18 Interventions that ameliorate 
these pathophysiologic effects of malnutrition may reduce the risk of complications, 
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readmissions and deaths after RC. Uncertainty remains whether delaying RC for pre-
operative nutritional interventions may undermine the patient’s chance for cure from RC. 
Although the optimal timeframe from diagnosis of MIBC to RC is debated19–21, some may 
be better served with pre-surgical optimization.
The premise for this recommendation is the assumption that pre-operative malnutrition is 
potentially modifiable, and improving nutrition status will improve outcomes after surgery. 
This notion is supported by the results of a large randomized clinical trial evaluating an 
individualized nutritional intervention during and after discharge from an acute 
hospitalization among a cohort of medical inpatients.22 The nutritional support intervention 
increased serum albumin levels and decreased mortality compared to the control group. Less 
optimistically however, Burden et al concluded that whether the benefits of pre-operative 
nutrition in patients undergoing gastrointestinal surgery outweigh the risks remains unclear.7 
Further research is essential to determine the optimal patient population, route, and timing of 
pre-operative nutrition interventions.
Identifying RC candidates at risk for malnutrition who may benefit from perioperative 
nutrition support is required in order to improve surgical outcomes. This population is 
potentially substantial, as patients undergoing RC have several risk factors for malnutrition. 
The association between advanced age and risk of malnutrition is well established.23 The 
mean age of patients diagnosed with bladder cancer is 73 years24 and the mean age at the 
time of RC in two contemporary cohorts is 68 years.10,11 Greater than 40% of 2,538 patients 
undergoing RC in a nationwide Veterans Administration database between 1991 and 2002 
were older than 70 years of age.4 Karl et al. demonstrated that age and malignant disease are 
independent risk factors for malnutrition among urologic inpatients in Germany.25 Two 
recent cohorts reported that 17–19% of bladder cancer patients undergoing radical 
cystectomy were nutritionally deficient as defined by serum albumin < 3.5 g/dL, BMI < 
18.5, and/or unintentional pre-operative weight loss >5%.10,11 Importantly, using the 
validated Nutritional Risk Score screening tool13 to define patients at risk for malnutrition, 
up to 55% of patients undergoing RC are at high risk.26,27
Pre-operative screening has little benefit unless accompanied by a formal, systematic 
nutritional assessment to clearly define an intervention plan and subsequent follow up and 
reevaluation.28 At our institution, a registered dietician formally consults on all patients 
scheduled to undergo RC pre-operatively. Laboratory values, including albumin, pre-
albumin, and C-reactive protein are obtained at the pre-operative visit. The goal of the 
nutrition consult is to assess risk and formulate an individualized plan for pre-operative 
nutrition supplementation, which may include carbohydrate loading and/or 
immunonutrition, if appropriate. On post-operative day 3, a follow up inpatient nutrition 
consult is obtained to reassess nutritional needs and create a personalized nutrition plan upon 
discharge. Follow up nutrition assessments occur on an outpatient basis (e.g. determining 
ongoing weight loss after discharge or impairment in wound healing) in coordination with 
post-operative visits and cancer surveillance appointments at an interval deemed appropriate 
by the nutritionist. Prospective collection of nutritional parameters, complications, 
readmission, and mortality is ongoing and will hopefully demonstrate an area for 
reproducible quality improvement.
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Limitations of our study include the retrospective design, although the well validated, 
standardized, prospective nature by which perioperative outcomes are ascertained mitigate 
some of the measurement and recording bias inherent to retrospective studies. The NSQIP 
data file does not yet include clinicopathologic data, making it impossible to adjust for 
extent of disease in our multivariable analysis. Additionally, a large proportion of patients 
were missing pre-operative albumin data. Finally, gastrointestinal complications including 
ileus and small bowel obstruction, which are particularly relevant after RC are absent from 
the data file at the current time.
Our study demonstrates that decreased pre-operative serum albumin is an independent risk 
factor for complications after RC for bladder cancer. Though imperfect as a marker for 
malnutrition, serum albumin may be useful in pre-operative counseling and risk-
stratification prior to RC. Additionally, serum albumin may be helpful in identifying patients 
who may benefit from pre-operative nutrition counseling and optimization.
Supplementary Material
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Table 1a
Distribution of demographic and prognostic characteristics among bladder cancer patients who underwent 








Sexa Male 65 (64) 465 (79) <0.01
Female 37 (36) 122 (21)
Raceb African American 13 (14) 24 (4) <0.01
Hispanic 1 (1) 14 (3)
Other 0 (0) 5 (0.9)
White 78 (85) 506 (92)
Resident presence in ORc Yes 65 (71) 390 (74) 0.57
No 26 (29) 135 (26)
Level of resident surgeon in ORd No resident 22 (27) 92 (21) 0.02
PGY 1 3 (4) 5 (1)
PGY 2 3 (4) 10 (2)
PGY 3 5 (6) 27 (6)
PGY 4 13 (16) 55 (12)
PGY 5 20 (24) 88 (20)
PGY 6+ 17 (20) 171 (38)
Year of operatione 2005, 2006, 2007, 2008, 
or 2009
34 (33) 151 (26) 0.11
2010, 2011, or 2012 68 (67) 438 (74)
Diabetes mellitus treated with oral agents or 
insuline
Diabetic treated with 
insulin
7 (7) 27 (5) 0.60
Diabetic treated with 
oral agents
13 (13) 84 (14)
Not diabetic 82 (80) 478 (81)
Smoker in past yeare Yes 32 (31) 145 (25) 0.15
No 70 (69) 444 (75)
More than 2 alcoholic drinks in 2 weeks prior to 
admissione
Yes 5 (5) 26 (4) 0.83
No 97 (95) 563 (96)
Functional statuse At least partially 
dependent
9 (9) 7 (1) <0.01
Independent 93 (91) 582 (99)
One or more pulmonary comorbidities (dyspnea, 
ventilator dependence, COPD, and/or 
pneumonia)e
Yes 23 (23) 91 (15) 0.07
No 79 (77) 498 (85)
One or more cardiac comorbidities (CHF, MI, 
angina, PCI, and/or previous cardiac surgery)e
Yes 16 (16) 98 (17) 0.81





















No 86 (84) 491 (83)
Hypertension requiring medicatione Yes 61 (60) 346 (59) 0.84
No 41 (40) 243 (41)
Preoperative acute renal failuree Yes 6 (6) 4 (0.7) <0.01
No 96 (94) 585 (99)
Preoperative dialysise Yes 0 (0) 2 (0.3) 0.56
No 102 (100) 587 (100)
One or more vascular comorbidities 
(revascularization and/or rest pain)e
Yes 1 (1) 8 (1) 0.76
No 101 (99) 581 (99)
One or more neurological comorbidities (coma, 
hemiplegia, TIA, CVA with neurological deficit, 
CVA without neurological deficit, tumor 
involving CNS, paraplegia, and/or quadriplegia)e
Yes 8 (8) 29 (5) 0.23
No 94 (92) 560 (95)
Steroid use for chronic conditione Yes 2 (2) 20 (3) 0.45
No 100 (98) 569 (97)
Greater than 10% loss in body weight in the last 6 
monthse
Yes 5 (5) 21 (4) 0.51
No 97 (95) 568 (96)
Bleeding disordere Yes 5 (5) 22 (4) 0.57
No 97 (95) 567 (96)
Radiotherapy for malignancy in last 90 dayse Yes 3 (3) 1 (0.2) <0.01
No 99 (97) 588 (100)
Prior operation within 30 daysf Yes 9 (9) 37 (6) 0.33
No 92 (91) 550 (94)
ASA classificatione ASA 1 and 2 13 (13) 139 (24) 0.01
ASA 3, 4 and 5 89 (87) 450 (76)
Transfused more than 4 units pRBCs in 72 hours 
prior to surgerye
Yes 8 (8) 8 (1) <0.01







Age (years)g 70 (61–78) 68 (61–76) 0.31
Operative time (min) 312 (247–426) 329 (258–423) 0.32




























Missing 4 from Preoperative albumin >= 3.5 category
h
Missing 2 from Preoperative albumin < 3.5 category and 4 from Preoperative albumin >= 3.5 category
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Table 1b
Distribution of selected demographic and prognostic characteristics among bladder cancer patients who 
underwent cystectomy, with and without (excessive) preoperative weight loss
Greater than 10% loss 
in body weight in the 
last 6 months
[n (%)]
Less than 10% loss in 




Sexa Male 30 (75) 899 (77) 0.80
Female 10 (25) 272 (23)
Raceb African American 3 (9) 49 (5) 0.65
Hispanic 0 (0) 26 (3)
Other 0 (0) 7 (0.7)
White 32 (91) 910 (92)
Resident presence in ORc Yes 30 (77) 751 (71) 0.45
No 9 (23) 302 (29)
Level of resident surgeon in ORd No resident 4 (15) 210 (23) 0.90
PGY 1 0 (0) 12 (1)
PGY 2 0 (0) 23 (3)
PGY 3 2 (7) 65 (7)
PGY 4 5 (19) 146 (16)
PGY 5 6 (22) 199 (22)
PGY 6+ 10 (37) 251 (28)
Year of operation 2005, 2006, 2007, 2008, 
or 2009
10 (25) 277 (24) 0.84
2010, 2011 or 2012 30 (75) 896 (76)
Diabetes mellitus treated with oral agents or 
insulin
Diabetic treated with 
insulin
2 (5) 61 (5) 0.26
Diabetic treated with 
oral agents
2 (5) 167 (14)
Not diabetic 36 (90) 945 (81)
Smoker in past year Yes 13 (33) 285 (24) 0.24
No 27 (67) 888 (76)
More than 2 alcoholic drinks in 2 weeks prior 
to admission
Yes 0 (0) 54 (5) 0.25
No 40 (100) 1119 (95)
Functional status At least partially 
dependent
2 (5) 20 (2) 0.16
Independent 38 (95) 1153 (98)
One or more pulmonary comorbidities 
(dyspnea, ventilator dependence, COPD, and/or 
pneumonia)
Yes 11 (28) 192 (16) 0.06
No 29 (73) 981 (84)
One or more cardiac comorbidities (CHF, MI, 
angina, PCI, and/or previous cardiac surgery)
Yes 9 (23) 188 (16) 0.28
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Greater than 10% loss 
in body weight in the 
last 6 months
[n (%)]
Less than 10% loss in 




No 31 (78) 985 (84)
Hypertension requiring medication Yes 23 (58) 681 (58) 0.94
No 17 (43) 492 (42)
Preoperative acute renal failure Yes 1 (3) 11 (0.9) 0.33
No 39 (98) 1162 (99)
Preoperative dialysis Yes 0 (0) 2 (0.2) 1.00
No 40 (100) 1171 (100)
One or more vascular comorbidities 
(revascularization and/or rest pain)
Yes 0 (0) 19 (2) 1.00
No 40 (100) 1154 (98)
One or more neurological comorbidities (coma, 
hemiplegia, TIA, CVA with neurological 
deficit, CVA without neurological deficit, 
tumor involving CNS, paraplegia, and/or 
quadriplegia)e
Yes 1 (3) 63 (5) 0.72
No 39 (98) 1109 (95)
Steroid use for chronic condition Yes 0 (0) 36 (3) 0.63
No 40 (100) 1137 (97)
Bleeding disorder Yes 0 (0) 41 (4) 0.64
No 40 (100) 1132 (97)
Radiotherapy for malignancy in last 90 days Yes 0 (0) 6 (0.5) 1.00
No 40 (100) 1167 (99)
Prior operation within 30 daysf Yes 5 (13) 63 (5) 0.07
No 35 (88) 1106 (95)
ASA classification ASA 1 and 2 11 (28) 319 (27) 1.00
ASA 3, 4, and 5 29 (73) 854 (73)
Transfused more than 4 units pRBCs in 72 
hours prior to surgery
Yes 5 (13) 25 (2) <0.01
No 35 (88) 1148 (98)
Greater than 10% loss 
in body weight in the 
last 6 months (median 
[IQR])
Less than 10% loss in 
body weight in the last 
6 months (median 
[IQR])
Age (years)g 73 (66–78) 69 (61–76) 0.09
Operative time (min) 300 (219–371) 320 (252–412) 0.14




























Missing 8 from Less than 10% loss in body weight in the last 6 months category
i
Missing 12 from Less than 10% loss in body weight in the last 6 months category
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Table 1c
Distribution of body mass index among bladder cancer patients who underwent cystectomy, with and without 




Sex Malea 28.0 (24.7–31.2) <0.01
Femaleb 26.5 (22.8–32.2)




Resident present in OR Yesd 28.2 (24.7–31.7) 0.01
Noe 27.0 (23.6–31.1)
Level of resident surgeon in OR No residentc 26.8 (23.6–31.0) 0.07
PGY 1 29.2 (26.4–31.7)
PGY 2 29.0 (25.7–35.4)
PGY 3 28.2 (25.2–30.8)
PGY 4c 28.2 (24.9–32.6)
PGY 5e 27.8 (24.1–31.0)
PGY 6+c 28.1 (24.7–32.0)
Year of operation 2005, 2006, 2007, 2008, or 2009f 28.0 (24.3–32.1) 0.93
2010, 2011 or 2012g 27.8 (24.4–31.3)
Diabetes mellitus treated with oral agents or insulin Diabetic treated with insulin 28.7 (25.8–34.5) <0.01
Diabetic treated with oral agentsb 29.8 (26.4–33.6)
Not diabetica 27.4 (24.1–30.8)
Smoker in past year Yesf 26.2 (23.0–30.3) <0.01
Nog 28.2 (24.8–31.9)
More than 2 alcoholic drinks in 2 weeks prior to admission Yes 25.6 (23.7–29.3) 0.02
Noh 28.0 (24.4–31.6)
Functional status At least partially dependentc 25.8 (21.3–30.1) 0.10
Independenti 27.8 (24.4–31.5)
One or more pulmonary comorbidities (dyspnea, ventilator 
dependence, COPD, and/or pneumonia)
Yesc 28.0 (23.7–31.9) 0.94
Noi 27.8 (24.4–31.4)
One or more cardiac comorbidities (CHF, MI, angina, PCI, and/or 
previous cardiac surgery)
Yesf 28.2 (24.7–31.9) 0.18
Nog 27.6 (24.3–31.4)

















Hypertension requiring medication Yesj 28.6 (25.0–32.3) <0.01
Nok 26.6 (23.6–30.1)
Preoperative acute renal failure Yes 26.8 (23.4–33.7) 0.84
Noh 27.8 (24.4–31.5)
Preoperative dialysis Yes 33.9 (32.2–35.5) 0.09
Noh 27.8 (24.4–31.5)
One or more vascular comorbidities (revascularization and/or rest 
pain)
Yes 28.6 (25.8–32.8) 0.33
Noh 27.8 (24.4–31.5)
One or more neurological comorbidities (coma, hemiplegia, TIA, 
CVA with neurological deficit, CVA without neurological deficit, 
tumor involving CNS, paraplegia, and/or quadriplegia)
Yesc 28.1 (24.1–32.2) 0.96
Noi 27.8 (24.4–31.5)
Steroid use for chronic condition Yesc 28.9 (26.1–31.9) 0.20
Noi 27.8 (24.4–31.5)
Greater than 10% loss in body weight in the last 6 months Yes 24.0 (21.3–28.8) <0.01
Noh 28.0 (24.5–31.6)
Bleeding disorder Yes 27.5 (24.6–30.4) 0.89
Noh 27.8 (24.4–31.5)
Radiotherapy for malignancy in last 90 days Yes 30.2 (23.7–32.2) 0.76
Noh 27.8 (24.4–31.5)
Prior operation within 30 days Yesc 26.8 (24.1–30.1) 0.19
Noi 27.9 (24.4–31.6)
ASA classification ASA 1 and 2f 27.3 (24.0–30.3) 0.01
ASA 3, 4 and 5g 28.1 (24.5–32.1)
Transfused more than 4 units pRBCs in 72 hours prior to surgery Yes 27.6 (22.2–30.4) 0.23
Noh 27.8 (24.4–31.5)
BMI (Unadjusted OR)
Age (per 10 year change in age)l −0.8 <0.01
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Table 2a
Predictors of overall complications following cystectomy for treating bladder cancer, with special emphasis on 
selected nutritional-dependent prognostic factors [albumin distribution dichotomized at 3.5]
Adjusted odds ratio (95% CI) p-value*
Preoperative albumin < 3.5 Yes 1.79 (1.06, 3.03) 0.03
No Reference
Greater than 10% loss in body weight in the last 6 months Yes 1.05 (0.44, 2.52) 0.92
No Reference
BMI Per 1 unit increase 1.01 (0.98, 1.04) 0.73
*
After adjusting for significant variables on bivariable analysis (BMI, age, sex, resident presence in OR, year of operation, smoking history, pre-
operative pulmonary and cardiac comorbidity, pre-operative acute renal failure, prior operation within 30 days, operative time, ASA classification, 
pre-operative blood transfusion). Remaining nutritional parameters were included in the multivariable model regardless of bivariable significance.
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Table 2b
Predictors of overall complications following cystectomy for treating bladder cancer, with special emphasis on 
selected nutritional-dependent prognostic factors [continuous albumin distribution]
Adjusted odds ratio (95% CI) p-value*
Preoperative albumin Per 0.5 mg/dL decrease 1.20 (1.02, 1.40) 0.02
Greater than 10% loss in body weight in the last 6 months Yes 1.03 (0.43, 2.49) 0.94
No Reference
BMI Per 1 unit increase 1.00 (0.97, 1.03) 0.84
*
After adjusting for significant variables on bivariable analysis (BMI, age, sex, resident presence in OR, year of operation, smoking history, pre-
operative pulmonary and cardiac comorbidity, pre-operative acute renal failure, prior operation within 30 days, operative time, ASA classification, 
pre-operative blood transfusion). Remaining nutritional parameters were included in the multivariable model regardless of bivariable significance.
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